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Peptide arrays on cellulose are a powerful tool to investigate peptide interactions with
a number of different molecules, for examples antibodies, receptors or enzymes. Such
peptide arrays can also be used to study interactions with whole cells. In this review,
we focus on the interaction of small antimicrobial peptides with bacteria. Antimicrobial
peptides (AMPs) can kill multidrug-resistant (MDR) human pathogenic bacteria and
therefore could be next generation antibiotics targeting MDR bacteria. We describe the
screen and the result of different optimization strategies of peptides cleaved from the
membrane. In addition, screening of antibacterial activity of peptides that are tethered to
the surface is discussed. Surface-active peptides can be used to protect surfaces from
bacterial infections, for example implants.
Keywords: SPOT-synthesis, antimicrobial peptides, peptide synthesis, antimicrobial screening, peptide libraries,
substitution analysis, multi-drug resistance, tethered peptides
ANTIMICROBIALS AND MICROBIAL RESISTANCE
Since their introduction in the 1930’s, antibiotics have been heralded as the wonder discovery of
the twentieth century; in the 75 years since their initial introduction (Davies and Davies, 2010),
the foundations surrounding the way physicians and health care practitioners care for patients has
shifted from a focus on diagnostics, toward a more treatment focused approach that has saved
millions of lives worldwide (Spellberg et al., 2011). Undoubtedly, access to efficient antibiotics is of
critical importance to society, with numerous procedures including; organ transplants, orthopedic
surgery and chemotherapy carrying high, if not prohibitive risk without the accessibility of these
antimicrobial agents (Höjgård, 2012). In fact, in the aftermath of this indisputable success, in late
1960’s US Surgeon General William H. Stewart stated: “it is time to close the book on infectious
diseases and declare the war against pestilence won” (Spellberg et al., 2008). Unfortunately, these
seven decades of medical advances and the effectiveness of any novel antibiotic is compromised by
the relentless appearance of drug resistant organisms, exhibiting resistance against one or more
antibiotic types (Spellberg et al., 2011). The (O’Neill, 2016) commissioned by the former UK
Prime Minister David Cameron, estimates that as of 2014, 700,000 people die annually from anti-
microbial resistance (AMR) bacterial infections, costing the US health care system alone, $20 billion
(O’Neill, 2016). Even more worryingly, these numbers are set to rise, with an estimated 10 million
people predicted to succumb to AMRs by 2050 at an increasing global cost of $100 trillion. While
the trends of AMR are difficult to predict, it is estimated that the death toll could be as high as one
person every 3 s if this issue is not immediately addressed (O’Neill, 2016). While these statistics
are frightening, this fate could be avoided by implementing certain interventions including: global
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public awareness campaigns, a reduction in the number of
unnecessary prescriptions, dramatic reduction and restrictions of
antibiotics in agriculture, development of rapid diagnostics and
most importantly, the development of novel antimicrobial agents
(Spellberg et al., 2011; O’Neill, 2016).
A large proportion of pharmaceutical companies have lost
interest in the antibiotic market despite an overall increase in
their research and development (R&D) budgets (A.A.D., 2004).
In fact, as of 2013, only four big pharmaceutical companies have
antibiotic programmes remaining (Fair and Tor, 2014).While the
reasons for this are multifactorial, one main reason is that is has
become substantially more difficult than it once was to develop
a new antimicrobial, particularly against AMR Gram-negative
bacteria. In addition, priced at a maximum of $1,000–$3,000 per
course, antibiotics hold a very small profit margin in comparison
to pharmaceuticals commonly used for long-term illness, which
can reach in excess of $80,000 (Bartlett et al., 2013). Therefore,
it is critical that pharmaceutical companies are provided an
incentive to revitalize interest in antibiotic development.
ANTIMICROBIAL PEPTIDES
Antimicrobial peptides (AMPs) are a diverse family of short
length molecules, between 5 and 50 amino acids in length and
with most possessing an overall net positive charge to their
structure (Hancock and Patrzykat, 2002). These peptides have
been gaining attention over recent years as one of the more
promising alternatives to traditional antimicrobial drugs–they
can display broad spectrum killing properties to Gram-positive
and Gram-negative bacteria, fungi, viruses, parasites and even
cancerous cells, are fast acting and have a decreased likelihood
to induce pathogenic resistance as compared to traditional
antimicrobial drugs (Marr et al., 2006).
Over 2,000 AMPs, both natural and lab-synthesized, have
been documented and submitted to the Antimicrobial Peptide
Database (APD3) (Wang et al., 2009; Zhao et al., 2013). In
2016, the APD3 contained 2,169 antibacterial and 959 antifungal
peptides. AMPs can be found naturally in a huge variety of
organisms—in animals, plants and even in fungi and bacteria
(Leippe, 1999; Radek and Gallo, 2007). It is now understood
that these molecules are a major part of the innate immune
system of animals, with a large quantity of them localized to
the organs and tissues most at risk of coming into contact
with pathogens, such as the skin, airways, digestive tract and
other epithelial surfaces and mucous membranes (Wiesner
and Vilcinskas, 2010). Through release by immune cells, such
as phagocytes and T-cells, AMPs are able to rapidly target
and kill pathogenic threats (Diamond et al., 2009). They are
playing a role in host inflammatory response by their action in
modulating cytokine response subsequent to infection, as was
recently shown for example when the AMP LL-37 decreased
the cytokine response of human neutrophils after infection
with S. aureus and P. aeruginosa (Alalwani et al., 2010).
Conversely, AMPs have also shown the ability to upregulate
immune response, such as human A-defensins, produced in
neutrophil cells, which have been shown to promote the
production of pro-inflammatory cytokines (van Wetering et al.,
1999).
The cationic nature of most AMPs means that they interact
strongly with negatively charged molecules. Therefore,
the selectivity of most AMPs relies on a fundamental
difference in the architecture of mammalian and microbial
membranes (Yeaman and Yount, 2003), allowing the peptide
to selectively kill microorganisms (Matsuzaki, 2009). These
include; differences in membrane composition, transmembrane
potential and membrane polarization as well as other features
including lipopolysaccharide (LPS), sterols, glycerides and
peptidoglycan (Yeaman and Yount, 2003). The outside of
bacterial membranes is rich in negatively charged phospholipids,
such as: phosphatidylglycerol, phosphatidylethanolamine and
cardiolipin (Zasloff, 2002). Further anionic molecules also exist
in the bacterial cell wall, including lipoteichoic acids in the
peptidoglycan of Gram-positive bacteria and LPS present in the
outer membrane of Gram-negative bacteria (Matsuzaki, 2009;
Guilhelmelli et al., 2013). In comparison, the negatively charged
phospholipids of mammalian membranes usually reside in the
inner leaflet of the bilayer (Zasloff, 2002), while the outermost
leaflet, the layer exposed to the cytoplasm, is populated by the
neutral phospholipids sphingomyelin, phosphatidylcholine, as
well as sterols, such as cholesterol (Matsuzaki, 2009; Guilhelmelli
et al., 2013). This difference in the charge of mammalian and
microbial membranes means that AMPs show different affinities
toward each respective membrane.
Another key variance between mammalian and microbial
cells is the difference in the charge separation between
the intra- and extracellular components of the cytoplasmic
membrane. This transmembrane potential (Yeaman and Yount,
2003), dictated by the interactions between the negatively
charged peptide and the phospholipid headgroups (Teixeira
et al., 2012), is a result of the different rates and extents
of proton flux over the cell membrane. In bacterial cells,
this transmembrane potential is more negative, ranging from
−130mv to −150mV in comparison to mammalian cells,
with a range of −90mv to −110mV (Yeaman and Yount,
2003). Because cells with a more negative transmembrane
potential facilitate membrane permeabilisation by encouraging
cationic peptides to insert themselves into the membrane
(Matsuzaki, 2009), cationic peptides canmore easily permeabilise
the bacterial cells, further providing AMPs with a means
of selectivity toward microbial cells (Yeaman and Yount,
2003). A study performed by Matsuzaki supported this theory
by demonstrating that the binding constant of the peptide
tachyplesin is increased 200-fold when the membrane potential
is as low as−120mV (Matsuzaki et al., 1997; Yeaman and Yount,
2003).
Anionic AMPs can interact by amidation of the C-terminus
(maxim H5) (Dennison et al., 2015), or through the formation
of salt bridges by metal ions (Harris et al., 2009). Once this
association has been completed, the AMP can be inserted into the
membrane via the hydrophobic regions of its structure (Madani
et al., 2011). AMPs can exert their antimicrobial effect by acting
on the outside of their target at the cell membrane, or they can
function by entering the cell and interacting with intracellular
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proteins or disrupting key processes, such as RNA- and DNA-
synthesis.
For some AMPs a combination of extra- and intracellular
activity is required for the death of their target (Koo et al.,
2001). A major mechanism by which certain AMPs carry out
their function on an intracellular level is by the inhibition of
DNA, RNA and protein synthesis (Hilpert et al., 2010). Buforin
2, an AMP found in the stomach of Bufo gargarizans, the Asian
toad, is able to penetrate the cell membrane via the action of
a proline hinge and bind to DNA and RNA (Kobayashi et al.,
2000; Xie et al., 2011), likely due to the similarity in sequence
between buforin 2 and histone H2A’s N-terminus (Cho et al.,
2009). Indolicidin, isolated from bovine neutrophil granules, has
been shown to bind to DNA where it blocks DNA-dependent
enzymes, such as integrase from binding (Marchand et al., 2006).
The central PWWP amino acid motif, a feature common to
proteins involved in DNA binding (Hale and Hancock, 2007) has
also shown importance in stabilizing the DNA structure once
the peptide has attached (Ghosh et al., 2014). Attacin is able
to contribute to destabilization of the membrane of E. coli by
preventing the transcription of the omp gene, thereby blocking
the synthesis of important outer membrane proteins (Carlsson
et al., 1991). It was also described that proline-rich peptides
can bind the chaperon DnaK and the ribosome (Krizsan et al.,
2015; Knappe et al., 2016a). Short AMPs can interact with ATP
and inhibit ATP depended enzymes critical for the survival of
the bacteria (Hilpert et al., 2010). AMPs are also capable of
preventing cell wall synthesis. Peptidoglycan is a major structural
component of bacteria, being the main constituent of the cell
wall in Gram-positive organisms and linked with the outer cell
membrane in Gram-negative bacteria, providing protection and
support. An important precursor of its synthesis is lipid 2, which
has been shown to be the target of several AMPs including
HND-1 (de Leeuw et al., 2010) and Cg-Defh-1 (Schmitt et al.,
2010).
PEPTIDE LIBRARIES
Screening of compounds libraries is well established as a high-
throughput method for detecting and studying interactions
in both biological and chemical systems. Libraries can be
composed of various types of molecules, ranging from small
organic compounds to peptides, proteins and RNA/DNA.
Many important processes in life are regulated by peptides
of different size and complexity. Well-known examples are
peptide hormones, like insulin, peptide neurotransmitters (e.g.,
opioid peptides) that influence pain and mood and peptides that
influence digestion and vascular functions. There are peptides
that support the immune system like (AMPs). In many biological
toxins, from plants (fungi, phalloidin) to animals (honey bee,
apamin), peptides play an important role (Jakubke and Sewald,
2009). Proteins play key roles in many cellular processes and
in some cases can be recapitulated by shorter peptides taken
from the primary protein sequences (although often with partial
loss of activity). Peptides have come into the focus of the
pharmacological industry not only based on high potency, but
also their high selectivity and safety. The global peptide drug
market was US$14.1 billion in 2011 and is estimated to reach
US$25.4 billion in 2018 (Fosgerau and Hoffmann, 2015). Hence,
peptide libraries can serve as valuable tools for identifying and
optimizing biologically active compounds. Biological synthesized
peptide libraries, such as phage, yeast, bacterial or ribosomal
mRNA displays (Ullman et al., 2011) rely on (i) creating a diverse
genetic library in which the phenotype (binding to target) of each
member of the library is linked to its genotype (the encoding
DNA or RNA), and (ii) an iterative cycle in which library
members are selected for binding to a target, and then amplified
(by replication in a host cell, or by copying of the encoded nucleic
acid in vitro). These techniques allow the selection of highly
active peptides due to several rounds of enrichment and a huge
number of different peptide sequences (over 109) that can be
displayed.
However, even being nowadays possible (Tian et al., 2004),
the use of non-natural amino acids is still difficult. Through
optimization of the chemistry, automation and miniaturization
of solid-phase peptide synthesis, chemical peptide libraries can be
built using different solid supports (resin beads, pins, glass chips,
tea bags, and cellulosemembranes) not being restrictive to the use
of gene-coded amino acids (Houghten, 1985; Weinberger et al.,
1997; Tribbick, 2002; Weiser et al., 2005; Breitling et al., 2009,
2011; Diehnelt, 2013).
For the efficient analysis of large peptides libraries, an
automated computer-based analysis of experimental results
is crucial. It consists of a quantitative analysis of activity
measurements (e.g., to compute activity-related values based on
luminescence measurements of a dilution series Mikut, 2010)
and the generation of new promising candidate sequences for a
synthesis. The latter step can be done (i) based on a systematic
substitution of single amino acids in a sequence or (ii) the
computation of molecular descriptors of a sequence followed by a
model-based evaluation of activity predictions (Cherkasov et al.,
2009; Mikut and Hilpert, 2009; Torrent et al., 2011; Fernandes
et al., 2012; Müller et al., 2016). Only few methods exist for
the prediction of toxic effects to get an early insight in the
therapeutic potential, see for example Cruz-Monteagudo et al.
(2011). However, many relevant experimental procedures, e.g.,
for a detailed analysis of blood interactions (Yu et al., 2015), are
not yet established for high-throughput screens. In this review,
we will focus on screens for (AMPs) synthesized by the SPOT-
synthesis technique.
PEPTIDE SPOT-SYNTHESIS
The basic concept of SPOT-synthesis is based on the capacity
of reactions to run until completion in a porous and planar
surface when enough reagents solution that the membrane is
able to absorb is added. This observation was made separately
for combinatorial nucleotides and peptide synthesis (Frank et al.,
1983; Frank and Doring, 1988). Therefore, when a small droplet
of liquid is dispensed on a porous membrane substrate and low
volatility solvents containing reagents are used, the circular spot
formed by the droplet absorption acts as an open reactor. Using
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this principle a great number of reactions can be arranged as
arrays on a larger surface as firstly described by Frank et. al.
(Frank, 1992).
Peptides produced by the SPOT-synthesis can be used in
surface- and solution-phase bioassays. Parallel peptide assembly
on planar surfaces using the SPOT-technique comprises some
general steps that will be described in further detail: (i) selection
of a membrane and its functionalization to meet the chemical,
biological, and technical requirements of the synthesis and
screening method; (ii) attachment of spacers and/or linkers; (iii)
peptide synthesis by conventional solid-phase Fmoc-chemistry
(Merrifield, 1963); (iv) cleavage of side chain protecting groups;
and optional (v) peptide cleavage from themembrane for analysis
and liquid-phase bioassays.
Cellulose membranes are widely used as porous material
for the SPOT-synthesis. Cellulose is an inexpensive flexible,
hydrophilic material, resistant to the organic solvents and
basic conditions used during peptide synthesis. Moreover, it
is also stable in aqueous conditions and not toxic being
appropriate to be used in biochemical and biological assays.
Cellulose filter papers are available in almost all laboratories
and different types of these commercially available filters have
been described to be suitable for the use by SPOT-synthesis,
namely Whatman Chr1, Whatman 50, or Whatman 540 (Hilpert
et al., 2007a; Lacroix and Li-Chan, 2014). TFA-soluble cellulose
membrane can be used to obtain soluble peptide-cellulose
conjugates that can be subsequently spotted onto glass slides to
produce CelluSpots microarrays (Chenggang and Li, 2009). A
series of alternative materials have been proposed as substrates
when non-compatible polysaccharide chemistry needs to be
performed: Polyvinylidene difluoride (PVDF), nitrocellulose,
polytetrafluoroethylene (PTFE/Teflon), acrylate-coated PTFE,
polystyrene-grafted PTFE. Many types of optimized membranes
are commercially available from AIMS Scientific Products. Deiss
et.al. have recently reported patterned deposition of Teflon
on paper allowing parallel flow-through peptide synthesis on
paper that are not possible with standard membranes where the
relationship between spot size and solution volume limits the
volume that can be deposited onto the support (Deiss et al., 2014).
Cellulose membranes possess hydroxyl groups at the surface
with low reactivity. Arrays of spot reactors providing suitable
anchor functions for peptide coupling are often obtained by
esterification of the hydroxyl groups. The most commonly
utilized derivatization of cellulose consist in the coupling of
beta-alanine-OH due to the molecules flexibility and linear
structure (Weiser et al., 2005). Higher functionalization with
subsequent potential higher yield has been described with
glycine functionalization (Kamradt and Volkmer-Engert, 2004).
Alternatives to cellulose esterification has been also proposed
as the use of 2,6-dichlorobenzoyl chloride (Sieber, 1987), the
activation of the amino acids with MSNT (1-(mesitylene-2-
sulfonyl)-3-nitro-1,2,4-triazole) (Blankemeyermenge et al., 1990)
or the Mitsunobu-reaction (Barlos et al., 1987). Fmoc-amino
acid fluorides have been shown to be highly reactive, but their
synthesis is time-consuming and arginine cannot be produced
(Wenschuh et al., 1999). Furthermore, they are not stable
enough during SPOT-synthesis. P-hydroxymethyl-benzoic acid
(HMBA) has also been proposed as a orthogonal safety-catch
linkage suitable for peptides, peptoids and carbohydrate-peptide
conjugates (VolkmerEngert et al., 1997).
Some protein domains require a free carboxyl-terminus (C-
terminus) for ligand recognition. Peptides synthesized according
to the standard SPOT-synthesis protocol lack a free C-terminus
due to the coupling to the cellulose support. The approach
proposed by Licha et al. to produce peptides with free C-
terminus uses an Fmoc-amino acid 3-bromopropyl esters and
mercapto-functionalized cellulose membranes (Licha et al.,
2000). Alternatively, peptides with free C-terminus have been
successfully produced by reversing the peptide orientation
(inverted peptides) (Boisguerin et al., 2004). The pioneering work
of Kania et al. (1994) for free C-terminal peptide synthesis on
solid phase have been recently adapted to produce a 340-member
library of peptides containing free C-termini on cellulose
membranes (Wang and Distefano, 2012). A different strategy
using 1,10-carbonyl-di-imidazole (CDI) or 1,10-carbonyl-di-
(1,2,4-triazole) (CDT) activators has been also reported as an
convenient approach to produce peptides with free C-terminal
end by SPOT-synthesis (Ay et al., 2007a).
The size of the spots on the support is defined by the dispensed
volume, the physical properties of the membrane surface and the
solvent(s). The spot size together with the minimum distance
between the spots limits the number of peptides that can be
synthesized permembrane area (Tong et al., 2002; Tonikian et al.,
2008). The SPOT-technique is particularly flexible regarding
peptide number that can be synthesized. In addition, there is
no special equipment needed although the laborious process
of the manual synthesis (Hilpert et al., 2007b) make it only
feasible when the aim is to produce a small number of peptides.
Manual SPOT-synthesis kits with a membrane large enough to
fit 96 spots are commercially available from Cambridge Research
Biochemicals and Sigma-Genosys. Process automation allows
the synthesis of up to 8000 different peptides on a 19∗29 cm
single sheet. Semi-automated and fully-automated synthesizers
for SPOT-technique are commercially available, for example
Intavis Bioanalytical Instruments and MultiSynTech.
Fmoc-chemistry is used for the SPOT-technique with two
possibilities for the preparation of the coupling solution
containing activated amino acids: in-situ activated or already
pre-activated Fmoc-protected amino acids. For amino acids in-
situ activation, an activator and a coupling reagent are added
to the no activated Fmoc-protected amino acid derivative. The
activations can be carried out by almost all known procedures:
DIC/HOBT; HATU, HBTU, or TBTU with bases as DIPEA,
PyBOP/DIC, or EEDQ. Pentafluorophenyl (OPfp) amino acids
derivatives are normally used for the pre-activation strategy,
which makes the preparation of coupling solutions very simple.
However, only particular pre-activated amino acids (i.e., all
common L-amino acids) are commercially available and the pre-
activated derivatives of nonstandard amino acids would need to
be synthesized or in-situ activation can be used instead. In both
methods, 0.2–0.5M solutions of Fmoc-protected derivatives are
generally dissolved in NMP that are subsequently deprotected
with 20% piperidine solutions. Capping steps by acetylation after
each cycle are highly recommended to assure that inefficient
Frontiers in Chemistry | www.frontiersin.org 4 April 2017 | Volume 5 | Article 25
López-Pérez et al. Optimizing AMPs via SPOT-Synthesis
couplings only gives rise to truncated sequences. Bromophenol
blue (BPB) staining as free amino indicator allows the visual
monitoring of the proper performance of the synthesis steps, such
as correct dispensing, coupling, capping and effective removal of
piperidine from Fmoc-deprotection steps.
When using Fmoc/tBu strategy for the peptide synthesis,
side chain deprotection by concentrated TFA treatment will
be required. When cellulose membranes are used, the cleavage
treatment regime for resin solid-phase peptide synthesis (i.e.,
around 90–95%TFA for 2–4 h) would not be feasible due to
the cellulose degradation at high acid concentrations. Cellulose
would last for about 3 h at 50% TFA concentration or around 1 h
at 90% (Hilpert et al., 2007a). To overcome that problem, several
cleavage cocktails and incubation times have been proposed and
reviewed previously (Hilpert et al., 2007a). Short incubations at
high TFA concentrations followed by longer reactions at around
50% TFA used to give good results even for the Pbf arginine
protecting group that need normally higher TFA concentration
to be cleaved (Hilpert et al., 2007b).
Peptide release from the membrane can be achieved by
the cleavage of the peptide C-terminal bond and the cellulose
membrane. Hydrolysis at high pH can be used for peptides
coupled by ester bonds. Treatment of ester linkage from HMBA,
glycolic acid or similar with 10 mM sodium hydroxide give the
peptide free acids. The treatment of the dry membranes with
ammonia vapors yields soluble peptide carboxamides. Reported
cleavage strategies has been also extensively reviewed (Wenschuh
et al., 2000; Frank, 2002; Hilpert et al., 2007a).
One of the main advantages of the SPOT-synthesis is the
molecule versatility that can be produced. The chemical and
technical performance has been optimized for the assembly of
peptide structures including: linear, cyclic, branched molecules
including D and L, coded and noncoded amino acids derivatives
and commercially available building blocks even for non-peptidic
compounds. Moreover, the peptides can be labeled for detection
purposes or for surface immobilization (Toepert et al., 2003;
Winkler and McGeer, 2008).
SPOT-synthesis is based on conventional solid-phase
synthesis and the same problems are observed. The quality of
SPOT-synthesized peptides has been extensively investigated
and peptide purity between 50 and 96% were reported. HPLC
analysis of SPOT-synthesized short peptides of up to 15 amino
acids showed similar purities to those synthesized by solid-
phase methods in reactors (Wenschuh et al., 2000). Peptide
purity higher than 92% has been reported by Takahashi et al.
(2000), while when a huge number of SPOT-synthesized
cytomegalovirus deduced nonameric peptides where analyzed by
HPLC/MS peptide purity in the range of 50–85% was found (Ay
et al., 2007b). Purities of 74.4–91.3% has been reported byMolina
and co-workers (Molina et al., 1996). Even longer peptides, such
as the 34-meric FBP28 WW domain could be SPOT-synthesized
with a high quality of 65% purity (Przezdziak et al., 2006) or
38mer peptides described by Toepert et al. (2001). Besides
the high synthetic peptide quality, equivalent peptide array
quality is achieved by applying identical chemical conditions
during array synthesis. Therefore, taking peptide arrays from
the same cellulose membrane (intra-membrane arrays) is highly
recommended. As far as possible, this would ensure spots with
similar peptide density (peptide concentration in a spot).
SCREENING OF PEPTIDES SYNTHESIZED
BY SPOT-TECHNOLOGY FOR
ANTIMICROBIAL ACTIVITY
Screening of Soluble Peptides
To our best knowledge the first publication combining
peptide synthesis of AMPs on cellulose by SPOT-synthesis and
antimicrobial screen was published in 2005 by Hilpert et al.
(2005). Here the authors were investigating a linear variant
(RLARIVVIRVAR) of the cyclic 12mer peptide bactenecin
(RLCRIVVIRVCR). Bactenecin is a peptide discovered in bovine
neutrophils (Marzari et al., 1988), active against Gram-negative
and some Gram-positive bacteria. The linear variant Bac2A
showed similar activity profile, but somewhat improved toward
Gram-positive bacteria (Wu and Hancock, 1999). The minimal
inhibitory concentration (MIC) against Pseudomonas aeruginosa
was determined in Mueller-Hinton broth at 50µg/ml (Wiegand
et al., 2008). In order to gain a high yield the cellulose membrane
was modified with glycine (Kamradt and Volkmer-Engert, 2004).
The synthesis was performed via Fmoc-strategy. Side chain
deprotection was performed by using 90% trifluoracetic acid,
3% tri-isobutylsilane, 2% water, 1% phenol in dichlormethan for
30 min, followed by a second treatment for 120min with 50%
trifluoracetic acid, 3% tri-isobutylsilane, 2% water, 1% phenol in
dichlormethan. The cleavage of the peptide from the membrane
was performed by ammonia gas atmosphere using an overnight
incubation.
In order to make the screen as sensitive and fast as possible
the authors developed an assay where a luminescent strain of
P. aeruginosa (H1001) was used, containing the luciferase gene
cassette luxCDABE that was incorporated into the bacterial
chromosome (into the fliC gene) (Lewenza et al., 2005). The
authors demonstrated that the traditional time kill assay and this
new developed assay are very similar in their result. In recent
years, we have demonstrated that luminescence is not required
to use these cellulose-derived peptides. In several projects, we
have used unmodified bacteria to perform this screen with other
live/death stains.
The peptide Bac2A was systematically investigated by
changing each single position with 20 most occurring amino
acids in nature. This substitution matrix resulted in 228 unique
peptides (12 positions x 19 alternative amino acids). As a
negative control a peptide with no antimicrobial activity was used
(GATPEDLNQKLS-NH2). Each peptide was stepwise diluted
seven times (1/2 the concentration each) and the activity against
P. aeruginosa H1001 was determined. From this concentration
curve, an IC50 was determined and in relation to the positive
control (Bac2A) a proxy IC50 was calculated for each of the
peptides. Based on this data, for each position of Bac2A, the
effect of each amino acid substitution could be measured. For
example, positions 1 (R), 4 (R), 8 (I), 9 (R), and 12 (R)
are optimal occupied, since no other substitution, except for
cysteine at some positions, improved activity, in fact most of the
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substitutions drastically reduced the activity. It also confirm the
importance of the positive charge and that the hydrophobicity
can be achieved by different amino acids. In contrast, position
11 (A) showed many substitutions that strongly improved the
activity. Overall, the substitution of C, W, R, K, and H often
improved antibacterial activity, whereas A, D, E, and P never
improved the activity. Peptides that are synthesized by the
SPOT-technology are normally not purified, and the results
need to be confirmed with purified peptides. The authors have,
based on the substitution matrix, designed 11 single substitution
variants of Bac2A, 4 multiple substitution variants and 5 Bac2A-
derived 8mers with multiple substitutions. These peptides were
synthesized on resin and HPLC-purified and then the MIC
against three Gram-positive, three Gram-negative (including P.
aeruginosa) and one yeast was determined. The MIC values of
the purified peptides were compared to the IC50 values of the
crude peptide (SPOT-technology) and a good correlation of R
= 0.895, P < 0.01 by ANOVA was reported. That supports
the observed IC50 data of the control peptide Bac2A that was
synthesized and tested at several different syntheses and showed
very robust data for 50 replicates with 0.13 ± 0.04. There were
three peptides with single substitution found that improved the
MIC against P. aeruginosa from 50 to 8 µg/ml and two of the
multiple substitution peptides reduced the MIC to 2µg/ml. It
was also confirmed that introducing a proline in the sequence
decreases activity to >250µg/ml. One 8mer peptide also showed
promise with an MIC of 8µg/ml against P. aeruginosa. The
detailed method for producing peptides on cellulose sheets and
the use of luminescent bacteria to screen for (AMPs) synthesized
on cellulose was published in Nature Protocols 2007 (Hilpert and
Hancock, 2007; Hilpert et al., 2007b). Jenssen et al. used this data
to evaluate different descriptors for the design of (AMPs) with
enhanced activity (Jenssen et al., 2007). The best outcome was a
correct predicted activity that reached 84%.
In 2006, a publication described the very same synthesis and
screening approach to investigate possible optimization strategies
in more detail (Hilpert et al., 2006). Peptides were synthesized
on cellulose with a glycine linker to gain high yield, side chain
deprotection and cleavage of the peptide from the membrane was
performed as described before. In our opinion, there were three
important observations described: First, substitution analysis as a
tool to optimize an antimicrobial peptide was confirmed. Second,
even in this very flexible 12mer peptide a substitution in one
position of the peptide effects distant positions. In this example,
the substitution of position three influences position 11. Third,
neither the primary sequence of the peptides nor the composition
of amino acids alone determines the antibacterial activity for
these short (AMPs). This was shown by 49 scrambled variants
of the 12mer Bac2A (RLARIVVIRVAR-NH2) that indicates the
whole bandwidth of activity from non-active to superior active.
The data shows that there is one or more hidden features that
also contribute to the antibacterial activity. In a quantitative
sequence activity relationship study using a computational
analysis and descriptors that translates sequence ordering and
fragment-based hydrophobicity into meaningful numbers, a
hydrophobic patch was discovered that was able to classify the
peptides. In addition, circular dichroism (CD) revealed that
the interaction with liposomes consisting of PPG/POPC 1:1 in
10mM Tris buffer pH7.4 induced a strong structural change in
the spectra compared to only buffer (random structure profile).
These changes occurred in the active peptides but not in the
less active peptides. Similar results obtained by a membrane
depolarization assay using E. coli strengthened the data obtained
by CD spectra, showing strong and fast depolarization with active
peptides and only weak and slow depolarization with less active
peptides. The hydrophobic patch, CD and depolarisation hint
that the interaction with the membrane is a hidden feature that
influences activity and is hard to predict based on the sequence.
In this publication two peptides (VRLRIRVRVIRK-NH2 and
KRWRIRVRVIRK-NH2) showed an MIC value of 3µg/ml
against P. aeruginosa and 0.8µg/ml against S. epidermidis (in
Mueller-Hinton-broth).
The synthesis of hundreds of peptides via the SPOT-
technology and a direct cell based screen resulting in activities
ranging from totally inactive to highly active provides an optimal
training set for computational analysis and consequent peptide
design. Another advantage is that newly computer designed
peptides can be synthesized and screened in high numbers to
provide confidence in the design rules. In 2009, two publications
described that approach (Cherkasov et al., 2009; Fjell et al.,
2009). Three 9mer libraries were synthesized and screened
against P. aeruginosa in the previous described screening assay
using the luminescent strain H1001. The peptide libraries were
synthesized on Whatman 50 cellulose membranes using glycine
as a linker. Side chain deprotection procedure and membrane
cleavage protocol remained the same to what was reported before.
The first library consisted of 200 computer designed totally
random peptides, where each amino acid (except cysteine that
was excluded) had the same chance to be incorporated. The
screening result showed only inactive or weak active peptides. In
consequence, a second library was designed based on occurrence
of amino acids in short natural occurring (AMPs). This library
contained 943 members and besides inactive and weak active
peptides, 26% had similar activity to Bac2A and 2.3% were
superior to Bac2A. Based on this data a third library with 500
members was designed using an optimized parameter for the
probability of amino acids to be selected in the computer design
of new AMPs. This library was synthesized and screened as
described before and the antimicrobial performance improves,
48% were similar active to Bac2A and 5% are superior to Bac2A.
Thus, the parameter of the third library was used to computer
generate 100,000 peptide sequences. The data of library two
and three were used to train a QSAR model using “inductive”
chemical descriptors and an artificial intelligence approach based
on artificial neural networks. These descriptors take into account
all atoms of the peptides, including hydrogen and are sensitive
to the three-dimensional structure of the peptides. Therefore, all
100,000 peptides needed to be modeled by estimating structural
conformation based on energy minimization in the gas phase
using MMFF94 force field. The QSAR model predicted the
activity of all peptides, ranked them and grouped them into
four quartiles, 25,000 in each. The first 50 of each quartile were
then selected, synthesized on cellulose and screened against P.
aeruginosa. The correlation coefficient between themeasured and
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TABLE 1 | Overview of eight peptide libraries.
Library Number of peptides Number without outliers Superior active Active Weak active Inactive
1 200 185 0 (0.0%) 0 (0.0%) 98 (53.0%) 87 (47.0%)
2 943 928 35 (3.8%) 163 (17.6%) 635 (68.4%) 95 (10.2%)
3 500 493 15 (3.0%) 132 (26.8%) 302 (61.3%) 44 (8.9%)
AA0 600 599 0 (0.0%) 274 (45.7%) 302 (50.4%) 23 (3.8%)
SR 600 598 9 (1.5%) 448 (74.9%) 141 (23.6%) 0 (0.0%)
BM 600 598 6 (1.0%) 360 (60.2%) 232 (38.8%) 0 (0.0%)
5BM 600 593 46 (7.8%) 533 (89.9%) 14 (2.4%) 0 (0.0%)
EP 600 597 1 (0.2%) 168 (28.1%) 283 (47.4%) 145 (24.3%)
Number of peptides analyzed and associated activity classes against Pseudomonas aeruginosa. Outliers–peptides with implausible luminescence measurement values–were excluded
from subsequent analyses. All libraries were described before [(Cherkasov et al., 2009; Fjell et al., 2009; Mikut, 2010)].
predicted relative IC50 values was r
2
= 0.986 (linear regression)
supporting the accuracy of the model. This correlation was also
confirmed by 20 selected peptides that were HPLC purified
(>95%) and MIC values against different pathogens were
determined. Even though, the quartiles had extremely different
antibacterial activity, peptides from each quartile showed
similar hydrophobicity, charge and amphipathicity/hydrophobic
moment, supporting previous results about a hidden parameter
that also influences the activity (Hilpert et al., 2006). Two
peptides were selected and tested against a series of multidrug-
resistant (MDR) “superbugs,” including MDR P. aeruginosa,
methicillin-resistant Staphylococcus aureus (MRSA), extended
spectrum β-lactamase producing E. coli, vancomycin-resistant
Enterococcus faecalis and faecium (VRE) and Enterobacter cloacea
with derepressed chromosomal β-lactamase. Most MIC values
were between 0.8 and 12, especially peptide HHC-10 performed
very well. Overall the peptides did outperform all tested
conventional antibiotics. The highest MIC values were observed
for 2 VRE isolates, with values of 99 and 49µM, while other
VRE isolates showed MIC values between 1.5 and 12µM. The
peptide HHC-10 performed also well in an intraperitoneally (IP)
S. aureus infection in a murine model, significantly reducing the
bacterial load after 24 h under both administration route, IP and
IV at 4mg kg−1. While the QSAR model was extremely effective,
its complexity was such that an understanding of the rules
for activity was impossible. The data of the three libraries was
therefore re-analyzed using simpler to understand descriptors
in order to finally find understandable rules that define why
a short peptide is antibacterial or not. Mikut et al. answered
that question in a massive amount of synthesis and screening
work (Mikut et al., 2016). With an unprecedented number of
individual peptides synthesized and screened the authors have
showed that even elusive rules can be discovered and used
to improve antimicrobial activity. For that more than 3,500
individual peptides, that is more AMPs than stored in the APD3
data base, were synthesized and tested against P. aeruginosa,
showing the power of the SPOT-synthesis technology. Library
AA0 verifies that the right amino acid composition is important,
but not enough to explain the activity. Library SR uses optimized
amino acid composition from AA0 and was further restricted to
contain at least three positive charges and at least two tryptophan.
The results, see Table 1, show that about 75% of these peptides
are active, indicating the importance of a balance of charge and
hydrophobicity. Library BM showed that a computer model with
only one descriptor is not enough to describe activity, but five
models combined (library 5BM) achieve this with about 97%
accuracy, using simple descriptors only. As an example, dilution
series of 10 peptides in this library are shown in Figure 1.
Library EP looks at “exotic” peptides that were poorly
described by the other models. Comparing 5BM and SR revealed
that all weak active peptide had either too much or too little W
or R/K, respectively. In 5BM, this balance was more enforced. In
order to proof that the balance is an important feature, another
library with all combination of W and R in a 9mer peptide (512
peptides) was synthesized and tested, verifying that the “right”
balance leads to activity. It was shown that there is no positional
preference for amino acids. In addition, these short AMPs differ
from those that occur naturally. The most active three AMPs
identified from these libraries showed MIC values of 2.2–2.7
µmol l−1 against P. aeruginosa (in Mueller-Hinton broth). They
also showed broad spectrum activity as the other 9mer peptides
described before.
Two publications describe the use of SPOT-technology to
optimize proline rich antimicrobial peptides (PrAMPs) (Knappe
et al., 2016b). The peptide oncocin, a peptide isolated from
Oncopeltus fasciatus (large milkweed bug) is a 19mer peptide
with rather weak activities against Staphylococcus aureus and
Pseudomonas aeruginosa, however it was successful in a systemic
septicaemia infection model in mouse (Knappe et al., 2012).
A substitution analysis of oncocin was synthesized on a
cellulose membrane using the SPOT-technology, using glycine
as a linker amino acid to improve the yield. The same side
chain cleavage procedure and membrane cleavage procedure
was applied as previously described. In total 361 variants of
oncocin (VDKPPYLPRPRPPRRIYNR-NH2) were synthesized
and screened against a luminescent P. aeruginosa strain (H1001).
The screening was performed in 6.25% Mueller-Hinton-Broth
(1.3 g/L) containing 40mmol/L glucose, since oncocin is not
active in full media. TheMIC determination for selected peptides
against S. aureus and P. aeruginosa was performed in 12.5%
Mueller-Hinton-Broth. Analysis of the data showed that 25
substitutions at nine different amino acid positions increased
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FIGURE 1 | Luciferase assay measurement of 10 peptides and two controls of library 5BM placed on plate 5 of the screen. In the left subfigure, the
luminescence values of the positive and negative control on this plated are shown compared to the synthesized peptides. The right subfigure shows the same data
with the color-coded activity classification. One peptide sequence with very low luminescence values even for low concentrations was marked as superior active. The
concentration and the luminescence values were normalized to the maximum values of a dilution series. The classes were defined based on RelIC75 values. As an
example, the negative control that oscillates between relative luminescence values between 0.7 and 1 for different concentrations was classified as “inactive.”
the activity, whereas 86 substitutions led to a complete loss of
activity. The MIC data revealed that oncocin is very robust
toward substitutions of single amino acids, no strong change in
activity was observed. There was however double substitutions
that indeed change the activity strongly, against P. aeruginosa a
10 times improvement was observed resulting in anMIC value of
4–8µg/mL and against S. aureus a 100-fold more active variant
than the original oncocin was discovered showing an MIC value
of 0.5 µg/mL.
A second PrAMP was investigated using the same approach.
Apidaecin is an 18mer peptide that was isolated from the
honey be (Apis mellifera). Apidaecin and its variant were also
successfully used inmousemodels (Czihal et al., 2012). Apidaecin
(GNNRPVYIPQPRPPHPRL-OH) is inactive against S. aureus
and very weakly active against P. aeruginosa (500µg/ml in 1/8
Mueller-Hinton broth). The aim of the project was to improve
these activities (Hoffmann et al., 2012). For the substitution
analysis, 341 unique peptides were synthesized via the SPOT-
technology and tested against P. aeruginosa in 1/8 Mueller-
Hinton broth. The result of this analysis is presented in Figure 2.
The substitution analysis reveals that an additional positive
charge improves the activity nearby at each position. Such
generalized results can be identified by looking for more active
variants and the manual interpretation of similarities of the
related amino acids, here caused by lysine and arginine indicating
the positive charge. In accordance with this, a negative charge
would decrease the activity dramatically, see columns for aspartic
acid and glutamic acid substitutions. In addition, the N-terminal
part can still be optimized, whereas the C-terminal part is quite
sensitive to most substitutions. Based on this analysis, several
peptides were re-synthesized on resin and HPLC purified. MIC
values against three strains were determined in 1/8 Mueller-
Hinton broth (MH, 2.5 g/L), results are given in Table 2.
By substituting a glycine on position one to a N,N,N0,N′-
tetramethylguanidino-ornithine and substituting three amino
acids that were identified by substitution analysis, the activity
against P. aeruginosa could be increased by 125-fold. By the very
same substitutions (without position 1), a peptide with no activity
against S. aureus was now highly active showing an MIC value
of 2µg/ml. This example again demonstrates the power of the
method.
Bluhm et al. reported the use of SPOT-synthesis to optimize an
apidaecin variant Api137 (gu-ONNRPVYIPRPRPPHPRL-OH)
(Bluhm et al., 2015). Api 137 showed only activity in diluted
media and variants were required that were also active in ½
MH broth. The authors were concerned about a free C-terminus
and therefore changed the linker strategy to the HMBA-linker,
that was reported before (VolkmerEngert et al., 1997). The first
coupling at the membrane was performed with a beta-alanine.
HBTU in the presence of DIPEA as base (0.2mol/L each, 10mL
DMF, RT, 1 h) was used to couple the HMBA-linker. Fmoc-Leu-
OH (0.4mol/L) was coupled using DIC (0.2 mol/L) and DMAP
(8 mmol/L) in DMF (10mL) overnight. Benzoic anhydride
(0.2mol/L) dissolved in a mixture of pyridine (40mmol/L) and
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FIGURE 2 | Substitution analysis for Apidaecin (GNNRPVYIPQPRPPHPRL). The original sequence and amino acid positions are given in the first two columns.
The other rows (A–Y) identifies the amino acid replacements at each position. Each box in the matrix corresponds to a single peptide containing an additional glycine
at the C-terminus. The values within each box represent a RelIC75 value, determined by treatment of the Pseudomonas aeruginosa reporter strain H1001 with any
given peptide for 4 h. Boxes are color-coded by a dynamic range between blue and red: blue stands for improved activity compared to the parent peptide, green for
similar activity, and red indicates no activity. Empty boxes represent the original sequence.
DMF (10mL, 2 h) were applied to cap the remaining free anchors.
HBTU and NMM (0.4mol/L each) in DMF (10mL, RT, 2 h)
was used to obtain N,N,N′,N′-tetramethyl-guanidino-groups at
the N-termini. Cleavage with aqueous ammonia resulted in a
mixture of free-C-terminus and amidated C-terminus as well as
peptide with beta-alanine. Changing to aqueous trimethylamine
changed the cleavage product to free C-terminus, however a
large part of the peptides still showed the beta alanine linker as
undesired side product. Api 137 purity was determined by HPLC
to be 57%. The impurities were not affecting the antimicrobial
activity and the screen using the complete substitution analysis
was performed. The authors identified four peptides, all single
substitutions that were eight times more active in 50%MH broth
compared to Api137. All multiple substitutions did not result in
further improvements.
The aforementioned 12mer peptides that were optimized
against antibacterial activity were also investigated for their
immunological properties. Based on this work K. Hilpert
designed peptide libraries HH1 to HH18 and to further improve
the library he designed IDR-1001 to IDR-1048. Some of these
peptides were very successful in several aspects, being potent
innate defense regulators and also demonstrating potent anti-
biofilm activity (Wieczorek et al., 2010; Rivas-Santiago et al.,
2013; de la Fuente-Núñez et al., 2014). Haney et al. explored
this further with SPOT-synthesis using a restricted set of
amino acids and determining anti-biofilm properties but also
immune-modulatory activities (Haney et al., 2015). Two peptides
were investigated, IDR-1002 (VQRWLIVWRIRK-NH2) and
IDR-HH2 (VQLRIRVAVIRA-NH2) and based on this results new
peptides were designed.
Screening of Tethered Peptides
In 2009, a landmark publication showed that SPOT-synthesis
can be used to screen and optimize surface-tethered (AMPs)
(Hilpert et al., 2009). LaPorte et al. (1977) and Haynie et al.
(1995) showed previously that (AMPs) can be active whilst
tethered to a surface, however it was not followed up by the
scientific community. The 2009 publication inspired directly and
indirectly a lot of research on surface protection using (AMPs),
now a field that has been reviewed on its own right. Crucial for
the use of SPOT-synthesis and a screen for tethered peptides
was the stability of the peptides on the membrane. An HPLC
analysis of the supernatant of peptide spots, produced via the
standard procedure resulting in an ester between glycine and
the membrane, showed an almost completely release after 4 h
incubation at 37◦C in 100mM Tris-buffer. The linker strategy
was therefore changed to a N-CAPE linker, a strategy that allows
with further modification the synthesis of peptides with free
C-terminus (Licha et al., 2000; Bhargava et al., 2002). This N
-modified cellulose-amino-hydroxypropyl ether provided very
stable tethered peptides, showing no HPLC detectable traces after
4 h incubation at 37◦C in 100mM Tris-buffer. Peptides were
synthesized at 50 nmol/spot and 200 nmol/spot. In total, 122
tethered peptides were screened and 23 highly active peptides
were identified. These peptides were selected on their ability
to kill bacteria in solution. There was no correlation observed
between antimicrobial activities of tethered peptides compared
to the MIC of the peptides in solution. There was however the
observation that the 10 most active peptides on an MIC level
were also highly active when tethered. It was also shown that
the haemolytic activity of the peptides dropped once tethered to
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TABLE 2 | Antibacterial activity of Apidaecin (GNNRPVYIPQPRPPHPRL)
and analogs.
Peptide sequence MIC in 1/8 of MH [µg/mL]
P. aeruginosa E. coli S. aureus
GNNRPVYIPQPRPPHPRL-OH 500 5 >125
GNNRPVYIPQPRPPHPRL-NH2 250 1.25 >125
GWNRPVYIPQPRPPHPRL-NH2 64 1.25 63
GRNRPVYIPQPRPPHPRL-NH2 64–128 0.625 32
GNNRCVYIPQPRPPHPRL-NH2 125 10 31
GNNRRVYIPQPRPPHPRL-NH2 64 5 32
GNNRPVYRPQPRPPHPRL-NH2 64 0.313 63
GNNRPVYIPQPRRPHPRL-NH2 125 10 31
GNNRPVYIPQPRPCHPRL-NH2 250 20 16
GNNRPVYIPQPRPPHCRL-NH2 125 20 32
GNNRPVYIPQPRPPHPRR-NH2 125 1.25–2.5 125
GWNRPVYIPRPRPPHPRL-NH2 16–32 0.63 16
GWNRPVYIPQPRRPHPRL-NH2 64 5 4–8
GNNRPVYIPRPRRPHPRL-NH2 64 2.5 4
GWNRPVYIPRPRRPHPRL-NH2 32 2.5 2
gu-OWNRPVYIPRPRRPHPRL-NH2 4 8 8–16
Minimal inhibitory concentrations (MIC) were determined 12.5 % Mueller-Hinton broth.
gu-O = (N,N,N0,N’-tetramethylguanidino-ornithine).
Changes that were introduced into the parent sequence are marked in color.
a surface. The activity of the antimicrobial activity of selected
peptides were confirmed using other surface linking chemistry
and other types of surfaces. Several experiments were performed
to unravel the mode of action of these peptides. In a follow
up study, several of these peptides were attached to a titanium
surface using a copolymer brush (Gao et al., 2011). After the
characterization of the surface the antimicrobial activity was
tested and verified in a rat infection model.
SUMMARY AND OUTLOOK
Antimicrobial resistance is a natural phenomenon that is part of
microbial surviving strategies to secure resources and ecological
niches. Alexander Fleming already said: “It is not difficult tomake
microbes resistant to penicillin in the laboratory by exposing
them to concentrations not sufficient to kill them, and the same
thing has occasionally happened in the body. The time may
come when penicillin can be bought by anyone in the shops.
Then there is the danger that the ignorant man may easily
underdose himself and by exposing his microbes to non-lethal
quantities of the drug make them resistant.” Unfortunately, man
became extremely ignorant and careless and started to misuse
all the antibiotics on a large scale, accelerating the drive of
resistant organism. Antibiotics are misused in a metric ton scale
in animal farming, for example treating piglets to get fatter faster
and less ill under the terrible condition they are kept in mass
farming. A public awareness campaign is trying to change this
mind-set, however the next generation faces a very difficult time
with not much treatment options left for bacterial and fungal
infections. Often it is referred to as the return to medieval
medicine. This situation becomes more likely since the economic
prospects to develop novel antibiotics for pharma are rather
bleak and many companies dropped out from their antimicrobial
drug development program, 36 of them last year. That leads
to very little activity in this sector, for example last year 504
drug candidates entered clinical phase 2 and 3 studies for cancer
treatment, but only 37 for antimicrobials.
Antimicrobial peptides (AMPs) are possible new candidates
for the treatment of MDR bacterial infections since they are
able to kill MDR microbes. It is a very diverse class and already
different modes of actions were reported for different peptides,
making them very interesting as drugs with novel mode of action.
There is a substantial body of literature about antimicrobial
action and their immunomodulatory activities. There is however
a great lack of data about the translational aspect toward clinical
phase and this is also reflected in the few peptides that entered
clinical phase. In order to make detailed studies of these peptides,
a method is needed that allows the synthesis of sufficient material
to perform cell-based tests in a high throughput manner. SPOT
synthesis is used for such studies, because it is fully automated,
reasonable priced and produces enough material to perform a
few cell-based studies. This technique is now more than 25 years
old and many data is described that shows the impact, but also
a lot of chemistry to adapt the protocols to different biological
questions. Recent improvements in high density peptide arrays
have outperformed the SPOT technology in the field of binding
assays. However, for cell based assays, were more material is
needed, SPOT technology remains the lead.
Antimicrobial peptides (AMPs) were investigated using
the SPOT technology. It was shown that it is possible to
systematically improve the antimicrobial activity by using
substitution analysis. More than 100-fold improvements in
activity were reported. In addition, peptide libraries can be
designed and optimized to contain very potent antimicrobial
compounds. These data can be used as a base for bioinformatics
and powerful prediction algorithms were developed. In the
future, this technology can support the process of moving these
peptides toward clinical studies, for example peptide variants
and modifications can be screened for stability and activity in
serum/blood.
Unfortunately, (AMPs) are currently developed not only for
treatment of MDR infections in humans but also for animals
and plants. Mankind seems not to learn the lessons from
their ignorance but intensify their behavior. At that large scale
application resistant strains can develop. Since AMPs are a major
compound of the innate immune system of many organisms,
including plants and animals, bacterial and/or fungal strains that
will develop resistance to AMPs might threaten the ecology of
earth even further and can accelerate the dying of numerous
species.
AUTHOR CONTRIBUTIONS
PL, EG, LB, RM, and KH were writing different sections to the
paper. KH brought all parts together and wrote the paper in a
uniform style. All authors have than proofread the manuscript
and KH has finalized the manuscript.
Frontiers in Chemistry | www.frontiersin.org 10 April 2017 | Volume 5 | Article 25
López-Pérez et al. Optimizing AMPs via SPOT-Synthesis
ACKNOWLEDGMENTS
KH thanks the Institute of Infection and Immunity for a start
up grant. The authors would like to thank Sven Hofmann and
Jurnorain Gani for critical proof-reading of the manuscript.
We acknowledge support by Deutsche Forschungsgemeinschaft
(DFG) and Open Access Publishing Fund of Karlsruhe Institute
of Technology.
REFERENCES
A.A.D. (2004). Stagnates, Bad Bugs, No Drugs. As Antibiotic Discovery Stagnates A
Public Health Crisis Brews. Alexandria: Infectious Diseases Society of America.
Alalwani, S. M., Sierigk, J., Herr, C., Pinkenburg, O., Gallo, R., Vogelmeier, C.,
et al. (2010). The antimicrobial peptide LL-37 modulates the inflammatory and
host defense response of human neutrophils. Eur. J. Immunol. 40, 1118–1126.
doi: 10.1002/eji.200939275
Ay, B., Streitz, M., Boisguerin, P., Schlosser, A., Mahrenholz, C. C., Schuck, S. D.,
et al. (2007b). Sorting and pooling strategy: a novel tool tomap a virus proteome
for CD8 T-cell epitopes. Biopolymers 88, 64–75. doi: 10.1002/bip.20637
Ay, B., Volkmer, R., and Boisguerin, P. (2007a). Synthesis of cleavable peptides
with authentic C-termini: an application for fully automated SPOT synthesis.
Tetrahedron Lett. 48, 361–364. doi: 10.1016/j.tetlet.2006.11.093
Barlos, K., Gatos, D., Kallitsis, J., Papaioannou, D., Sotiriou, P., and Schafer, W.
(1987). Anchoring of amino-acids on hydroxy group-containing resins and
their application to peptide-synthesis using N-tritylamino acid 1-benzotriazolyl
esters. Liebigs Ann. Chem. 1031–1035.
Bartlett, J. G., Gilbert, D. N., and Spellberg, B. (2013). Seven ways to preserve the
miracle of antibiotics. Clin. Infect. Dis. 56, 1455–1450. doi: 10.1093/cid/cit070
Bhargava, S., Licha, K., Knaute, T., Ebert, B., Becker, A., Grötzinger, C., et al. (2002).
A complete substitutional analysis of VIP for better tumor imaging properties.
J. Mol. Recogn. 15, 145–153. doi: 10.1002/jmr.565
Blankemeyermenge, B., Nimtz, M., and Frank, R. (1990). An efficient method
for anchoring fmoc-amino acids to hydroxyl-functionalized solid supports.
Tetrahedron Lett. 31, 1701–1704.
Bluhm,M. E., Knappe, D., andHoffmann, R. (2015). Structure-activity relationship
study using peptide arrays to optimize Api137 for an increased antimicrobial
activity against Pseudomonas aeruginosa. Eur. J. Med. Chem. 103, 574–582.
doi: 10.1016/j.ejmech.2015.09.022
Boisguerin, P., Leben, R., Ay, B., Radziwill, G., Moelling, K., Dong, L., et al. (2004).
An improved method for the synthesis of cellulose membrane-bound peptides
with free C termini is useful for PDZ domain binding studies. Chem. Biol. 11,
449–459. doi: 10.1016/j.chembiol.2004.03.010
Breitling, F., Loﬄer, F., Schirwitz, C., Cheng, Y. C., Markle, F., Konig, K., et al.
(2011). Alternative setups for automated peptide synthesis. Mini Rev. Org.
Chem. 8, 121–131. doi: 10.2174/157019311795177763
Breitling, F., Nesterov, A., Stadler, V., Felgenhauer, T., and Bischoff, F. R. (2009).
High-density peptide arrays.Mol. Biosyst. 5, 224–234. doi: 10.1039/b819850k
Carlsson, A., Engström, P., Palva, E. T., and Bennich, H. (1991). Attacin,
an antibacterial protein from Hyalophora cecropia, inhibits synthesis of
outer membrane proteins in Escherichia coli by interfering with omp gene
transcription. Infect. Immun. 59, 3040–3045.
Chenggang, W., and Li, S. S.-C. (2009). CelluSpotsTM: a reproducible means of
making peptide arrays for the determination of SH2 domain binding specificity.
Methods Mol. Biol. 570, 197–202. doi: 10.1007/978-1-60327-394-7_8
Cherkasov, A., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S.
C., et al. (2009). Use of artificial intelligence in the design of small peptide
antibiotics effective against a broad spectrum of highly antibiotic-resistant
superbugs. ACS Chem. Biol. 4, 65–74. doi: 10.1021/cb800240j
Cho, J. H., Sung, B. H., and Kim, S. C. (2009). Buforins: histone H2A-derived
antimicrobial peptides from toad stomach. Biochim. Biophys. Acta 1788,
1564–1569. doi: 10.1016/j.bbamem.2008.10.025
Cruz-Monteagudo, M., Borges, F., and Cordeiro, M. N. (2011). Jointly handling
potency and toxicity of antimicrobial peptidomimetics by simple rules from
desirability theory and chemoinformatics. J. Chem. Inf. Model. 51, 3060–3077.
doi: 10.1021/ci2002186
Czihal, P., Knappe, D., Fritsche, S., Zahn, M., Berthold, N., Piantavigna, S.,
et al. (2012). Api88 is a novel antibacterial designer peptide to treat systemic
infections with multidrug-resistant gram-negative pathogens. ACS Chem. Biol.
7, 1281–1291. doi: 10.1021/cb300063v
Davies, J., and Davies, D. (2010). Origins and evolution of antibiotic resistance.
Microbiol. Mol. Biol. Rev. 74, 417–433. doi: 10.1128/MMBR.00016-10
Deiss, F., Matochko, W. L., Govindasamy, N., Lin, E. Y., and Derda,
R. (2014). Flow-through synthesis on teflon-patterned paper to produce
peptide arrays for cell-based assays. Angew Chem. Int. Ed. 53, 6374–6377.
doi: 10.1002/anie.201402037
de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., and Hancock, R.
E. W. (2014). Broad-spectrum anti-biofilm peptide that targets a cellular stress
response. PLoS Pathog. 10:e1004152. doi: 10.1371/journal.ppat.1004152
de Leeuw, E., Li, C., Zeng, P., Li, C., Diepeveen-de Buin, M., Lu, W. Y., et al.
(2010). Functional interaction of human neutrophil peptide-1 with the cell wall
precursor lipid II. FEBS Lett. 584, 1543–1548. doi: 10.1016/j.febslet.2010.03.004
Dennison, S. R., Mura, M., Harris, F., Morton, L. H., Zvelindovsky, A., and
Phoenix, D. A. (2015). The role of C-terminal amidation in the membrane
interactions of the anionic antimicrobial peptide, maximin H5. Biochim.
Biophys. Acta 1848, 1111–1118. doi: 10.1016/j.bbamem.2015.01.014
Diamond, G., Beckloff, N., Weinberg, A., and Kisich, K. O. (2009). The roles of
antimicrobial peptides in innate host defense.Curr. Pharm. Des. 15, 2377–2392.
doi: 10.2174/138161209788682325
Diehnelt, C. W. (2013). Peptide array based discovery of synthetic antimicrobial
peptides. Front. Microbiol. 4:402. doi: 10.3389/fmicb.2013.00402
Fair, R. J., and Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st
century. Perspect. Medicin. Chem. 6, 25–64. doi: 10.4137/PMC.S14459
Fernandes, F. C., Rigden, D. J., and Franco, O. L. (2012). Prediction of
antimicrobial peptides based on the adaptive neuro-fuzzy inference system
application. Biopolymers 98, 280–287. doi: 10.1002/bip.22066
Fjell, C. D., Jenssen, H., Hilpert, K., Cheung, W. A., Panté, N., Hancock, R. E., et al.
(2009). Identification of novel antibacterial peptides by chemoinformatics and
machine learning. J. Med. Chem. 52, 2006–2015. doi: 10.1021/jm8015365
Fosgerau, K., and Hoffmann, T. (2015). Peptide therapeutics: current
status and future directions. Drug Discov. Today 20, 122–128.
doi: 10.1016/j.drudis.2014.10.003
Frank, R. (1992). Spot-synthesis-an easy technique for the positionally addressable,
parallel chemical synthesis on a membrane support. Tetrahedron 48,
9217–9232. doi: 10.1016/s0040-4020(01)85612-x
Frank, R. (2002). The SPOT-synthesis technique. Synthetic peptide arrays on
membrane supports–principles and applications. J. Immunol. Methods 267,
13–26. doi: 10.1016/s0022-1759(02)00137-0
Frank, R., and Doring, R. (1988). Simultaneous multiple peptide-synthesis
under continuous-flow conditions on cellulose paper disks as segmental solid
supports. Tetrahedron 44, 6031–6040.
Frank, R., Heikens, W., Heisterbergmoutsis, G., and Blöcker, H. (1983). A new
general-approach for the simultaneous chemical synthesis of large numbers of
oligonucleotides-segmental solid supports. Nucleic Acids Res. 11, 4365–4377.
doi: 10.1093/nar/11.13.4365
Gao, G., Lange, D., Hilpert, K., Kindrachuk, J., Zou, Y., Cheng, J. T., et al.
(2011). The biocompatibility and biofilm resistance of implant coatings based
on hydrophilic polymer brushes conjugated with antimicrobial peptides.
Biomaterials 32, 3899–3909. doi: 10.1016/j.biomaterials.2011.02.013
Ghosh, A., Kar, R. K., Jana, J., Saha, A., Jana, B., Krishnamoorthy, J., et al.
(2014). Indolicidin targets duplex DNA: structural and mechanistic insight
through a combination of spectroscopy and microscopy. Chem. Med. Chem.
9, 2052–2058. doi: 10.1002/cmdc.201402215
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski Lda, S., Silva-Pereira,
I., and Kyaw, C. M. (2013). Antibiotic development challenges: the various
mechanisms of action of antimicrobial peptides and of bacterial resistance.
Front. Microbiol. 4:353. doi: 10.3389/fmicb.2013.00353
Frontiers in Chemistry | www.frontiersin.org 11 April 2017 | Volume 5 | Article 25
López-Pérez et al. Optimizing AMPs via SPOT-Synthesis
Hale, J. D., andHancock, R. E. (2007). Alternative mechanisms of action of cationic
antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 5, 951–959.
doi: 10.1586/14787210.5.6.951
Hancock, R. E., and Patrzykat, A. (2002). Clinical development of cationic
antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets
Infect. Disord. 2, 79–83. doi: 10.2174/1568005024605855
Haney, E. F., Mansour, S. C., Hilchie, A. L., de la Fuente-Núñez, C., and Hancock,
R. E. W. (2015). High throughput screening methods for assessing antibiofilm
and immunomodulatory activities of synthetic peptides. Peptides 71, 276–285.
doi: 10.1016/j.peptides.2015.03.015
Harris, F., Dennison, S. R., and Phoenix, D. A. (2009). Anionic antimicrobial
peptides from eukaryotic organisms. Curr. Protein Pept. Sci. 10, 585–606.
doi: 10.2174/138920309789630589
Haynie, S. L., Crum, G. A., and Doele, B. A. (1995). Antimicrobial activities of
amphiphilic peptides covalently bonded to a water-insoluble resin. Antimicrob.
Agents Chemother. 39, 301–307. doi: 10.1128/AAC.39.2.301
Hilpert, K., Elliott, M., Jenssen, H., Kindrachuk, J., Fjell, C. D., Körner,
J., et al. (2009). Screening and characterization of surface-tethered
cationic peptides for antimicrobial activity. Chem. Biol. 16, 58–69.
doi: 10.1016/j.chembiol.2008.11.006
Hilpert, K., Elliott, M. R., Volkmer-Engert, R., Henklein, P., Donini, O.,
Zhou, Q., et al. (2006). Sequence requirements and an optimization
strategy for short antimicrobial peptides. Chem. Biol. 13, 1101–1107.
doi: 10.1016/j.chembiol.2006.08.014
Hilpert, K., and Hancock, R. E. (2007). Use of luminescent bacteria for
rapid screening and characterization of short cationic antimicrobial peptides
synthesized on cellulose using peptide array technology. Nat. Protoc. 2,
1652–1660. doi: 10.1038/nprot.2007.203
Hilpert, K., McLeod, B., Yu, J., Elliott, M. R., Rautenbach, M., Ruden, S., et al.
(2010). Short cationic antimicrobial peptides interact with ATP. Antimicrob.
Agents Chemother. 54, 4480–4483. doi: 10.1128/aac.01664-09
Hilpert, K., Volkmer-Engert, R., Walter, T., and Hancock, R. E. (2005). High-
throughput generation of small antibacterial peptides with improved activity.
Nat. Biotechnol. 23, 1008–1012. doi: 10.1038/nbt1113
Hilpert, K., Winkler, D. F., and Hancock, R. E. (2007a). Cellulose-bound peptide
arrays: preparation and applications. Biotechnol. Genet. Eng. Rev. 24, 31–106.
doi: 10.1080/02648725.2007.10648093
Hilpert, K., Winkler, D. F., and Hancock, R. E. (2007b). Peptide arrays on cellulose
support: SPOT synthesis, a time and cost efficient method for synthesis of
large numbers of peptides in a parallel and addressable fashion. Nat. Protoc.
2, 1333–1349. doi: 10.1038/nprot.2007.160
Hoffmann, R., Knappe, D., Hilpert, K., Mikut, R., and Ruden, S. (2012). Modified
Apidaecin Derivatives as Antibiotic Peptides. United States Patent Application
20150344524A1. Universitaet Leipzig. Application number US 14/346,624;
PCT number PCT/EP2012/068620.
Höjgård, S. (2012). Antibiotic resistance-why is the problem so difficult to solve?
Infect. Ecol. Epidemiol. 2, 1–7. doi: 10.3402/iee.v2i0.18165
Houghten, R. A. (1985). General method for the rapid solid-phase synthesis of
large numbers of peptides: specificity of antigen-antibody interaction at the
level of individual amino acids. Proc. Natl. Acad. Sci. U.S.A. 82, 5131–5135.
doi: 10.1073/pnas.82.15.5131
Jakubke, H. D., and Sewald, N. (2009). Peptides: Chemistry and Biology, 2nd Edn.
Weinheim: Wiley Online Library.
Jenssen, H., Lejon, T., Hilpert, K., Fjell, C. D., Cherkasov, A., and Hancock, R.
E. (2007). Evaluating different descriptors for model design of antimicrobial
peptides with enhanced activity toward P. aeruginosa. Chem. Biol. Drug Des.
70, 134–142. doi: 10.1111/j.1747-0285.2007.00543.x
Kamradt, T., and Volkmer-Engert, R. (2004). Cross-reactivity of T
lymphocytes in infection and autoimmunity. Mol. Divers 8, 271–280.
doi: 10.1023/B:MODI.0000036236.11774.1b
Kania, R. S., Zuckermann, R. N., and Marlowe, C. K. (1994). Free C-terminal
resin-bound peptides-reversal of peptide orientation via a cyclization/cleavage
protocol. J. Am. Chem. Soc. 116, 8835–8836. doi: 10.1021/ja000
98a064
Knappe, D., Goldbach, T., Hatfield, M. P., Palermo, N. Y., Weinert, S., Sträter,
N., et al. (2016a). Proline-rich antimicrobial peptides optimized for binding
to Escherichia coli chaperone DnaK. Protein Pept. Lett. 23, 1061–1071.
doi: 10.2174/0929866523666160719124712
Knappe, D., Fritsche, S., Alber, G., Kohler, G., Hoffmann, R., andMüller, U. (2012).
Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic
septicaemia infection mouse model. J. Antimicrob. Chemother. 67, 2445–2451.
doi: 10.1093/jac/dks241
Knappe, D., Ruden, S., Langanke, S., Tikkoo, T., Ritzer, J., Mikut, R., et al. (2016b).
Optimization of oncocin for antibacterial activity using a SPOT synthesis
approach: extending the pathogen spectrum to Staphylococcus aureus. Amino
Acids 48, 269–280. doi: 10.1007/s00726-015-2082-2
Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., and Matsuzaki, K. (2000).
Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers:
proline as a translocation promoting factor. Biochemistry 39, 8648–8654.
doi: 10.1021/bi0004549
Koo, S. P., Bayer, A. S., and Yeaman, M. R. (2001). Diversity in antistaphylococcal
mechanisms among membrane-targeting antimicrobial peptides. Infect.
Immun. 69, 4916–4922. doi: 10.1128/iai.69.8.4916-4922.2001
Krizsan, A., Prahl, C., Goldbach, T., Knappe, D., and Hoffmann, R. (2015).
Short proline-rich antimicrobial peptides inhibit either the bacterial 70S
ribosome or the assembly of its large 50S subunit. Chembiochem 16, 2304–2308.
doi: 10.1002/cbic.201500375
Lacroix, I. M., and Li-Chan, E. C. (2014). Peptide array on cellulose support-
a screening tool to identify peptides with dipeptidyl-peptidase IV inhibitory
activity within the sequence of alpha-lactalbumin. Int. J. Mol. Sci. 15,
20846–20858. doi: 10.3390/ijms151120846
LaPorte, D. C., Rosenthal, K. S., and Storm, D. R. (1977). Inhibition of Escherichia
coli growth and respiration by polymyxin B covalently attached to agarose
beads. Biochemistry 16, 1642–1648. doi: 10.1021/bi00627a019
Leippe, M. (1999). Antimicrobial and cytolytic polypeptides of amoeboid
protozoa–effector molecules of primitive phagocytes.Dev. Comp. Immunol. 23,
267–279. doi: 10.1016/S0145-305X(99)00010-5
Lewenza, S., Falsafi, R. K., Winsor, G., Gooderham,W. J., McPhee, J. B., Brinkman,
F. S., et al. (2005). Construction of a mini-Tn5-luxCDABE mutant library in
Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated
genes. Genome Res. 15, 583–589. doi: 10.1101/gr.3513905
Licha, K., Bhargava, S., Rheinlander, C., Becker, A., Schneider-Mergener, J., and
Volkmer-Engert, R. (2000). Highly parallel nano-synthesis of cleavable peptide-
dye conjugates on cellulose membranes. Tetrahedron Lett. 41, 1711–1715.
doi: 10.1016/s0040-4039(00)00019-8
Madani, F., Lindberg, S., Langel, U., Futaki, S., and Gräslund, A. (2011).
Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys. 2011:
414729. doi: 10.1155/2011/414729
Marchand, C., Krajewski, K., Lee, H. F., Antony, S., Johnson, A. A., Amin, R., et al.
(2006). Covalent binding of the natural antimicrobial peptide indolicidin to
DNA abasic sites. Nucleic Acids Res. 34, 5157–5165. doi: 10.1093/nar/gkl667
Marr, A. K., Gooderham, W. J., and Hancock, R. E. (2006). Antibacterial peptides
for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6,
468–472. doi: 10.1016/j.coph.2006.04.006
Marzari, R., Scaggiante, B., Skerlavaj, B., Bittolo, M., Gennaro, R., and Romeo,
D. (1988). Small, antibacterial and large, inactive peptides of neutrophil
granules share immunoreactivity to a monoclonal antibody. Infect. Immun. 56,
2193–2197.
Matsuzaki, K. (2009). Control of cell selectivity of antimicrobial peptides. Biochim.
Biophys. Acta 1788, 1687–1692. doi: 10.1016/j.bbamem.2008.09.013
Matsuzaki, K., Sugishita, K., Harada, M., Fujii, N., and Miyajima, K. (1997).
Interactions of an antimicrobial peptide, magainin 2, with outer and inner
membranes of Gram-negative bacteria. Biochim. Biophys. Acta 1327, 119–130.
doi: 10.1016/s0005-2736(97)00051-5
Merrifield, R. B. (1963). Solid phase peptide synthesis. I. The synthesis of a
tetrapeptide. J. Am. Chem. Soc. 85, 2149–2154.
Mikut, R. (2010). Computer-based analysis, visualization, and interpretation
of antimicrobial peptide activities. Methods Mol. Biol. 618, 287–299.
doi: 10.1007/978-1-60761-594-1_18
Mikut, R., and Hilpert, K. (2009). Interpretable features for the activity prediction
of short antimicrobial peptides using fuzzy logic. Int. J. Pept. Res. Ther. 15,
129–137. doi: 10.1007/s10989-009-9172-5
Mikut, R., Ruden, S., Reischl, M., Breitling, F., Volkmer, R., and Hilpert,
K. (2016). Improving short antimicrobial peptides despite elusive rules for
activity. Biochim. Biophys. Acta 1858, 1024–1033. doi: 10.1016/j.bbamem.2015.
12.013
Frontiers in Chemistry | www.frontiersin.org 12 April 2017 | Volume 5 | Article 25
López-Pérez et al. Optimizing AMPs via SPOT-Synthesis
Molina, F., Laune, D., Gougat, C., Pau, B., and Granier, C. (1996). Improved
performances of spot multiple peptide synthesis. Pept. Res. 9, 151–155.
Müller, A. T., Kaymaz, A. C., Gabernet, G., Posselt, G., Wessler, S., Hiss, J. A.,
et al. (2016). Sparse neural network models of antimicrobial peptide-activity
relationships.Mol. Inform. 35, 606–614. doi: 10.1002/minf.201600029
O’Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and
Recommendations Review on Antimicrobial Resistance.
Przezdziak, J., Tremmel, S., Kretzschmar, I., Beyermann, M., Bienert, M.,
and Volkmer-Engert, R. (2006). Probing the ligand-binding specificity and
analyzing the folding state of SPOT-synthesized FBP28 WW domain variants.
Chembiochem 7, 780–788. doi: 10.1002/cbic.200500408
Radek, K., and Gallo, R. (2007). Antimicrobial peptides: natural effectors
of the innate immune system. Semin. Immunopathol. 29, 27–43.
doi: 10.1007/s00281-007-0064-5
Rivas-Santiago, B., Castañeda-Delgado, J. E., Santiago, C. E. R., Waldbrook, M.,
González-Curiel, I., Leon-Contreras, J. C., et al. (2013). Ability of innate
defence regulator peptides IDR-, IDR-HH2 and IDR-1018 to protect against
mycobacterium tuberculosis infections in animal models. PLoS ONE 8:e59119.
doi: 10.1371/journal.pone.0059119
Schmitt, P., Wilmes, M., Pugnière, M., Aumelas, A., Bachère, E., Sahl, H. G., et al.
(2010). Insight into invertebrate defensinmechanism of action: oyster defensins
inhibit peptidoglycan biosynthesis by binding to lipid II. J. Biol. Chem. 285,
29208–29216. doi: 10.1074/jbc.M110.143388
Sieber, P. (1987). An improved method for anchoring of 9-
fluorenylmethoxycarbonyl-amino acids to 4-Alkoxybenzyl alcohol resins.
Tetrahedron Lett. 28, 6147–6150. doi: 10.1016/s0040-4039(00)61832-4
Spellberg, B., Blaser, M., Guidos, R. J., Boucher, H. W., Bradley, J. S., Eisenstein,
B. I., et al. (2011). Gilbert, combating antimicrobial resistance: policy
recommendations to save lives: ISDA policy paper. Clin. Infect. Dis. 52, S397–
S428. doi: 10.1093/cid/cir153
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M.,
et al. (2008). The epidemic of antibiotic-resistant infections: a call to action for
the medical community from the infectious diseases society of America. Clin.
Infect. Dis. 46, 155–164. doi: 10.1086/524891
Takahashi, M., Ueno, A., and Mihara, H. (2000). Peptide design based on
an antibody complementarity-determining region (CDR): construction
of porphyrin-binding peptides and their affinity maturation by a
combinatorial method. Chemistry 6, 3196–3203. doi: 10.1002/1521-3765(20
000901
Teixeira, V., Feio, M. J., and Bastos, M. (2012). Role of lipids in the interaction
of antimicrobial peptides with membranes. Prog. Lipid Res. 51, 149–177.
doi: 10.1016/j.plipres.2011.12.005
Tian, F., Tsao, M. L., and Schultz, P. G. (2004). A phage display system
with unnatural amino acids. J. Am. Chem. Soc. 126, 15962–15963.
doi: 10.1021/ja045673m
Toepert, F., Knaute, T., Guﬄer, S., Pirés, J. R., Matzdorf, T., Oschkinat, H., et al.
(2003). Combining SPOT synthesis and native peptide ligation to create large
arrays of WW protein domains. Angew. Chem. Int. Ed. Engl. 42. 1136–1140.
doi: 10.1002/anie.200390298
Toepert, F., Pires, J. R., Landgraf, C., Oschkinat, H., and Schneider-
Mergener, J. (2001). Synthesis of an array comprising 837 variants of
the hYAP WW protein domain. Angew. Chem. Int. Ed. Engl. 40, 805.
doi: 10.1002/1521-3773(20010302)40:5<897::AID-ANIE897>3.0.CO;2-X
Tong, A. H. Y., Drees, B., Nardelli, G., Bader, G. D., Brannetti, L., Castagnoli, M.
et al. (2002). A combined experimental and computational strategy to define
protein interaction networks for peptide recognition modules. Science 295,
321–324. doi: 10.1126/science.1064987
Tonikian, R., Zhang, Y. N., Sazinsky, S. L., Currell, B., Yeh, J. H., Reva, B.,
et al. (2008). A specificity map for the PDZ domain family. PLoS Biol. 6:e239.
doi: 10.1371/journal.pbio.0060239
Torrent, M., Andreu, D., Nogués, V. M., and Boix, E. (2011). Connecting peptide
physicochemical and antimicrobial properties by a rational prediction model.
PLoS ONE 6:e16968. doi: 10.1371/journal.pone.0016968
Tribbick, G. (2002). Multipin peptide libraries for antibody and receptor
epitope screening and characterization. J. Immunol. Methods 267, 27–35.
doi: 10.1016/S0022-1759(02)00138-2
Ullman, C. G., Frigotto, L., and Cooley, R. N. (2011). In vitro methods for
peptide display and their applications. Brief. Funct. Genomics 10, 125–134.
doi: 10.1093/bfgp/elr010
vanWetering, S., Sterk, P. J., Rabe, K. F., and Hiemstra, P. S. (1999). Defensins: key
players or bystanders in infection, injury, and repair in the lung? J. Allergy Clin.
Immunol. 104, 1131–1138.
VolkmerEngert, R., Hoffmann, B., and SchneiderMergener, J. (1997). Stable
attachment of the HMB-linker to continuous cellulose membranes for parallel
solid phase spot synthesis. Tetrahedron Lett. 38, 1029–1032.
Wang, G., Li, X., and Wang, Z. (2009). APD2: the updated antimicrobial peptide
database and its application in peptide design. Nucleic Acids Res. 37, D933–
D937. doi: 10.1093/nar/gkn823
Wang, Y. C., and Distefano, M. D. (2012). Solid-phase synthesis of C-terminal
peptide libraries for studying the specificity of enzymatic protein prenylation.
Chem. Commun. 48, 8228–8230. doi: 10.1039/c2cc31713c
Weinberger, H., Lichte, E., Griesinger, C., and Kutscher, B. (1997). Small peptide
libraries: combinatorial split-mix synthesis followed by combinatorial amino
acid analysis of selected variants. Arch. Pharm. (Weinheim). 330, 109–111.
doi: 10.1002/ardp.19973300406
Weiser, A. A., Or-Guil, M., Tapia, V., Leichsenring, A., Schuchhardt, J.,
Frömmel, C., et al. (2005). SPOT synthesis: reliability of array-based
measurement of peptide binding affinity. Anal. Biochem. 342, 300–311.
doi: 10.1016/j.ab.2005.04.033
Wenschuh, H., Hoffman, B., Schaller, S., Germeroth, L., Schneider-Mergener, J.,
and Volkmer-Engert, R. (1999). “Efficient parallel synthesis of cellulose bound
and cleavable peptides via direct anchoring of fmoc-amino acid Fluorides
onto cellulose. Peptides 1998,” in Proceedings of the 25th European Peptide
Symposium, eds S. Bajusz and F. Hudecz. 772–773.
Wenschuh, H., Volkmer-Engert, R., Schmidt, M., Schulz, M., Schneider-Mergener,
J., and Reineke, U. (2000). Coherent membrane supports for parallel
microsynthesis and screening of bioactive peptides. Biopolymers 55, 188–206.
doi: 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T
Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R., Elliott, M.,
Hilpert, K., et al. (2010). Structural studies of a peptide with immune
modulating and direct antimicrobial activity. Chem. Biol. 17, 970–980.
doi: 10.1016/j.chembiol.2010.07.007
Wiegand, I., Hilpert, K., and Hancock, R. E. (2008). Agar and broth dilution
methods to determine the minimal inhibitory concentration (MIC) of
antimicrobial substances. Nat. Protoc. 3, 163–175. doi: 10.1038/nprot.2007.521
Wiesner, J., and Vilcinskas, A. (2010). Antimicrobial peptides: the ancient arm of
the human immune system. Virulence 1, 440–464. doi: 10.4161/viru.1.5.12983
Winkler, D. F., and McGeer, P. L. (2008). Protein labeling and biotinylation of
peptides during spot synthesis using biotin p-nitrophenyl ester (biotin-ONp).
Proteomics 8, 961–967. doi: 10.1002/pmic.200700909
Wu, M. H., and and, Hancock, R. E. W. (1999). Improved derivatives of
bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob.
Agents Chemother. 43, 1274–1276.
Xie, Y., Fleming, E., Chen, J. L., and Elmore, D. E. (2011). Effect of proline
position on the antimicrobial mechanism of buforin II. Peptides 32, 677–682.
doi: 10.1016/j.peptides.2011.01.010
Yeaman, M. R., and Yount, N. Y. (2003). Mechanisms of antimicrobial peptide
action and resistance. Pharmacol. Rev. 55, 27–55. doi: 10.1124/pr.55.1.2
Yu, K., Lai, B. F., Gani, J., Mikut, R., Hilpert, K., and Kizhakkedathu, J. N.
(2015). Interaction of blood components with cathelicidins and their modified
versions. Biomaterials 69, 201–211. doi: 10.1016/j.biomaterials.2015.08.003
Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415,
389–395. doi: 10.1038/415389a
Zhao, X., Wu, H., Lu, H., Li, G., and Huang, Q. (2013). LAMP:
a database linking antimicrobial peptides. PLoS ONE 8:e66557.
doi: 10.1371/journal.pone.0066557
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 López-Pérez, Grimsey, Bourne, Mikut and Hilpert. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Chemistry | www.frontiersin.org 13 April 2017 | Volume 5 | Article 25
